TrialPanorama/TrialPanorama-database huggingface dataset:
Study 35597252 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study 33484075 — Predictive Biomarker (PRD): PNPLA3 mRNA
Genes: PNPLA3; ADPN; C22orf20
Study 32112668 — Predictive Biomarker (PRD): F3 mRNA
Genes: F3
Study 32151851 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 32151851 — Surrogate Endpoint (SUR): Blood pressure
Study 34732695 — Predictive Biomarker (PRD); Safety Biomarker (SAF): SLC6A4 mRNA
Genes: SLC6A4; HTT; SERT
Study 34732695 — Safety Biomarker (SAF): SLC6A3
Genes: DAT
Study 34506311 — Predictive Biomarker (PRD): MME mRNA
Genes: MME; EPN
Study 34057186 — Surrogate Endpoint (SUR): Blood pressure
Study 32041601 — Surrogate Endpoint (SUR): Forced vital capacity
Study 34191090 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study 34191090 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 32153038 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study 34597743 — Predictive Biomarker (PRD): LPP mRNA
Genes: LPP
Study 35415998 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 35554270 — Surrogate Endpoint (SUR): Blood pressure
Study 33045675 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 33045675 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33045675 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33045675 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 33045675 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 33357708 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33357708 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 32321115 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 35211831 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 35491736 — Predictive Biomarker (PRD): CPD mRNA
Genes: CPD
Study 33011864 — Surrogate Endpoint (SUR): Forced vital capacity
Study 34831608 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 34831608 — Predictive Biomarker (PRD): SELENBP1 mRNA
Genes: SELENBP1; SBP
Study 34831608 — Surrogate Endpoint (SUR): Blood pressure
Study 33683065 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 35538687 — Predictive Biomarker (PRD): SCT mRNA
Genes: SCT
Study 32067871 — Surrogate Endpoint (SUR): Blood pressure
Study 33213976 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 33802219 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study 34264700 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study 34083331 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 34083331 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 34083331 — Predictive Biomarker (PRD): ROS1
Genes: MCF3; ROS; c-ros-1
Study 34083331 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 34083331 — Predictive Biomarker (PRD): CDKN2A mRNA
Genes: CDKN2A; CDKN2; MTS1
Study 34083331 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 34083331 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study 35124475 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 32798261 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32798261 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 35653744 — Predictive Biomarker (PRD): ERCC8 mRNA
Genes: ERCC8; CKN1; CSA
Study 35653744 — Predictive Biomarker (PRD): TRIT1 mRNA
Genes: TRIT1; IPT; MOD5
Study 35653744 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 33049235 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 32104685 — Predictive Biomarker (PRD): CARD8 mRNA
Genes: CARD8; DACAR; KIAA0955; NDPP1
Study 33639045 — Surrogate Endpoint (SUR): Bone mineral density
Study 33639045 — Surrogate Endpoint (SUR): Serum calcium
Study 35477531 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 35606820 — Predictive Biomarker (PRD): JAK1 mRNA
Genes: JAK1; JAK1A; JAK1B
Study 35606820 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study 35342931 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study 34548479 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 34548479 — Predictive Biomarker (PRD): Hormone receptor
Study 35181470 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 32676853 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 33070132 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 35812412 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 32826001 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 35773713 — Surrogate Endpoint (SUR): Bone mineral density
Study 34981467 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34981467 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34981467 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 34981467 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 34981467 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 33762239 — Predictive Biomarker (PRD); Safety Biomarker (SAF): RBPMS mRNA
Genes: RBPMS; HERMES
Study 33751659 — Predictive Biomarker (PRD): ARL2BP mRNA
Genes: ARL2BP; BART; BART1
Study 36477479 — Surrogate Endpoint (SUR): Blood pressure
Study 34281849 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 35200094 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 35200094 — Surrogate Endpoint (SUR): Blood pressure
Study 36011519 — Surrogate Endpoint (SUR): Blood pressure
Study 34332557 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 34332557 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 33778831 — Predictive Biomarker (PRD): CCL21 mRNA
Genes: CCL21; SCYA21; UNQ784/PRO1600
Study 35906331 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 32240018 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study 33055188 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study 34880156 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 32074302 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 32074302 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 32074302 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 32074302 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 34642026 — Predictive Biomarker (PRD): IGFBP2 mRNA
Genes: IGFBP2; BP2; IBP2
Study 33278625 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 34602110 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study 34602110 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 34172394 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 34172394 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 34172394 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33594643 — Surrogate Endpoint (SUR): Bone mineral density
Study 34378863 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 36403542 — Safety Biomarker (SAF): Reactive oxygen species
Study 35063965 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study 32072792 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study 36460535 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 35858825 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 33606921 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 35797111 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 35797111 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32402931 — Surrogate Endpoint (SUR): Serum creatinine
Study 35321739 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33531152 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 36355640 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study 34388379 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 34388379 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 33109641 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study 33109641 — Safety Biomarker (SAF): Hyaluronic acid
Study 35058236 — Safety Biomarker (SAF): c-Jun N-terminal kinase
Study 35058236 — Surrogate Endpoint (SUR): Forced vital capacity
Study 34854347 — Surrogate Endpoint (SUR): Blood pressure
Study 35822730 — Pharmacodynamic Biomarker (PDY): Transmembrane glycoprotein NMB
Genes: GPNMB; HGFIN; NMB; UNQ1725/PRO9925
Study 35822730 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 35822730 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 32803888 — Predictive Biomarker (PRD): AGA mRNA
Genes: AGA
Study 33461151 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study 35835346 — Surrogate Endpoint (SUR): Blood pressure
Study 33508845 — Surrogate Endpoint (SUR): Blood pressure
Study 35172685 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study 33964196 — Surrogate Endpoint (SUR): Blood pressure
Study 34292210 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34292210 — Safety Biomarker (SAF): IL-6 and IL-10
Study 35671086 — Predictive Biomarker (PRD): PDPN mRNA
Genes: PDPN; GP36; PSEC0003; PSEC0025
Study 35671086 — Predictive Biomarker (PRD): NNT mRNA
Genes: NNT
Study 36017205 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33668058 — Surrogate Endpoint (SUR): Blood pressure
Study 35627807 — Predictive Biomarker (PRD): SERPINA1 mRNA
Genes: SERPINA1; AAT; PI; PRO0684; PRO2209
Study 34461161 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 32005202 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 35461689 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study 32981056 — Surrogate Endpoint (SUR): Blood pressure
Study 32453346 — Surrogate Endpoint (SUR): Blood pressure
Study 36330051 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 34534517 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 32756556 — Predictive Biomarker (PRD): SRL mRNA
Genes: SRL
Study 33975149 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33975149 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 34406911 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 33876784 — Surrogate Endpoint (SUR): Blood pressure
Study 32988524 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 32085823 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 34178828 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study 34178828 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 34178828 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 34477812 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 34477812 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 33313858 — Predictive Biomarker (PRD): EBF1 mRNA
Genes: EBF1; COE1; EBF
Study 32880495 — Predictive Biomarker (PRD): MAP2K1 mRNA
Genes: MAP2K1; MEK1; PRKMK1
Study 32880495 — Predictive Biomarker (PRD): MAP2K2 mRNA
Genes: MAP2K2; MEK2; MKK2; PRKMK2
Study 32880495 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 33610365 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 32230754 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study 33851518 — Predictive Biomarker (PRD): NR1I2
Genes: ONR1; PXR; BXR; SXR; PAR2
Study 33851518 — Predictive Biomarker (PRD): MGP mRNA
Genes: MGP; MGLAP; GIG36
Study 33851518 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Osteopontin
Genes: SPP1; BNSP; OPN; PSEC0156
Study 33851518 — Predictive Biomarker (PRD): TNFRSF11B mRNA
Genes: TNFRSF11B; OCIF; OPG
Study 32333325 — Predictive Biomarker (PRD): MAP3K5 mRNA
Genes: MAP3K5; ASK1; MAPKKK5; MEKK5
Study 32333325 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CXCL1 mRNA
Genes: CXCL1; GRO; GRO1; GROA; MGSA; SCYB1
Study 36195927 — Predictive Biomarker (PRD): LRRC4 mRNA
Genes: LRRC4; BAG; NAG14; UNQ554/PRO1111
Study 36195927 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study 36195927 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 32780773 — Predictive Biomarker (PRD): AFM mRNA
Genes: AFM; ALB2; ALBA
Study 35717342 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 36056443 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 36056443 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 36412916 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 36412916 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 36203214 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 36203214 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 36203214 — Safety Biomarker (SAF): BDNF
Study 34077270 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 33057807 — Surrogate Endpoint (SUR): Bone mineral density
Study 32106110 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Growth/differentiation factor 15
Genes: GDF15; MIC1; PDF; PLAB; PTGFB
Study 33594772 — Predictive Biomarker (PRD): TBXT mRNA
Genes: TBXT; T
Study 33974178 — Predictive Biomarker (PRD): GYPC mRNA
Genes: GYPC; GLPC; GPC
Study 33974178 — Predictive Biomarker (PRD): FUT1 mRNA
Genes: FUT1; H; HSC
Study 33974178 — Predictive Biomarker (PRD): SDS mRNA
Genes: SDS; SDH
Study 33974178 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study 33974178 — Predictive Biomarker (PRD): SKIC2 mRNA
Genes: SKIC2; DDX13; SKI2W; SKIV2; SKIV2L; W
Study 33974178 — Predictive Biomarker (PRD): OCA2 mRNA
Genes: OCA2; D15S12; P
Study 36040559 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 36040559 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 35764956 — Predictive Biomarker (PRD): GCNT2 mRNA
Genes: GCNT2; GCNT5; II; NACGT1
Study 32223389 — Surrogate Endpoint (SUR): Blood pressure
Study 33264544 — Predictive Biomarker (PRD): Microsatellite instability
Study 33460574 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 33460574 — Predictive Biomarker (PRD): Hormone receptor
Study 33900931 — Predictive Biomarker (PRD): SDS mRNA
Genes: SDS; SDH
Study 33900931 — Predictive Biomarker (PRD): TSPAN31 mRNA
Genes: TSPAN31; SAS
Study 32507672 — Predictive Biomarker (PRD): EMD mRNA
Genes: EMD; EDMD; STA
Study 32439266 — Safety Biomarker (SAF): Lysosomal alpha-glucosidase
Genes: GAA
Study 35477178 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study 32196772 — Predictive Biomarker (PRD): MAL mRNA
Genes: MAL
Study 32196772 — Predictive Biomarker (PRD): HAL mRNA
Genes: HAL; HIS
Study 36075691 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32921090 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 32066654 — Surrogate Endpoint (SUR): Blood pressure
Study 36401492 — Surrogate Endpoint (SUR): Blood pressure
Study 35658487 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 35658487 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study 35658487 — Predictive Biomarker (PRD): Homologous recombination deficiency
Study 34749997 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study 35492335 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35492335 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 32443433 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33756503 — Surrogate Endpoint (SUR): Blood pressure
Study 33164570 — Predictive Biomarker (PRD): FMOD mRNA
Genes: FMOD; FM; SLRR2E
Study 35620920 — Surrogate Endpoint (SUR): Blood pressure
Study 1994041002 — Predictive Biomarker (PRD): GGT1 mRNA
Genes: GGT1; GGT
Study 1994041002 — Predictive Biomarker (PRD): KDM5D mRNA
Genes: KDM5D; HY; HYA; JARID1D; KIAA0234; SMCY
Study 34551207 — Predictive Biomarker (PRD): GLS mRNA
Genes: GLS; GLS1; KIAA0838
Study 35927580 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34727201 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study 34727201 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 34727201 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 35022283 — Predictive Biomarker (PRD): TPO mRNA
Genes: TPO
Study 35022283 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 35022283 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study 33547784 — Predictive Biomarker (PRD): SRI mRNA
Genes: SRI
Study 32045911 — Surrogate Endpoint (SUR): Blood pressure
Study 35983513 — Surrogate Endpoint (SUR): Serum sodium
Study 34225463 — Safety Biomarker (SAF): Ornithine transcarbamylase
Genes: OTC
Study 33236329 — Predictive Biomarker (PRD): Myeloid cell surface antigen CD33
Genes: CD33; SIGLEC3
Study 32895286 — Surrogate Endpoint (SUR): Blood pressure
Study 32684216 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 32684216 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32684216 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 32592725 — Predictive Biomarker (PRD): LPP mRNA
Genes: LPP
Study 36174484 — Surrogate Endpoint (SUR): Blood pressure
Study 33713841 — Predictive Biomarker (PRD): ACTG1 mRNA
Genes: ACTG1; ACTG
Study 33107110 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study 34391298 — Predictive Biomarker (PRD): FES mRNA
Genes: FES; FPS
Study 33394598 — Predictive Biomarker (PRD): EBF1 mRNA
Genes: EBF1; COE1; EBF
Study 36123398 — Predictive Biomarker (PRD): ACR mRNA
Genes: ACR; ACRS
Study 36123398 — Surrogate Endpoint (SUR): Blood pressure
Study 34601386 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35836919 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 32160420 — Surrogate Endpoint (SUR): Blood pressure
Study 32292492 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 32292492 — Safety Biomarker (SAF): Hemoglobin scavenger receptor
Genes: CD163; M130
Study 33067169 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 616886745 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 34073024 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 33574495 — Predictive Biomarker (PRD): MBP mRNA
Genes: MBP
Study 33574495 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 33574495 — Predictive Biomarker (PRD): PIP mRNA
Genes: PIP; GCDFP15; GPIP4
Study 33574495 — Surrogate Endpoint (SUR): Blood pressure
Study 32470492 — Surrogate Endpoint (SUR): Blood pressure
Study 32470492 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 34510703 — Surrogate Endpoint (SUR): Blood pressure
Study 32486525 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study 32486525 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study 36124697 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 35552078 — Surrogate Endpoint (SUR): Blood pressure
Study 32671684 — Predictive Biomarker (PRD): LAMA1 mRNA
Genes: LAMA1; LAMA
Study 34427481 — Surrogate Endpoint (SUR): Blood pressure
Study 35266281 — Predictive Biomarker (PRD): ABO mRNA
Genes: ABO
Study 35352176 — Predictive Biomarker (PRD): TOX mRNA
Genes: TOX; KIAA0808
Study 35461831 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF